937046-95-2 ((1H-吡咯-1-基)氨基甲酸叔丁酯,N-(1H-pyrrol-1-yl)(tert-butoxy)formamide)

CAS号:
937046-95-2
中文名称:
(1H-吡咯-1-基)氨基甲酸叔丁酯
英文名称:
N-(1H-pyrrol-1-yl)(tert-butoxy)formamide
分子式:
C9H14N2O2
分子量:
182.219662189484

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)名称与标识符

名称

中文别名:
(1H-吡咯-1-基)氨基甲酸叔丁酯;
英文别名:
tert-Butyl 1H-pyrrol-1-ylcarbamate;1-N-Boc-Aminopyrrole;Carbamic acid, N-1H-pyrrol-1-yl-, 1,1-dimethylethyl ester;Pyrrol-1-yl-carbamicacid tert-butyl ester;N-(1H-pyrrol-1-yl)-carbamic acid tert-butyl ester;N-(Boc-amino)pyrrole;QC-728;SC4442;PYRROL-1-YL-CARBAMIC ACID TERT-BUTYL ESTER;1,1-Dimethylethyl N-1H-pyrrol-1-ylcarbamate (ACI);tert-Butyl (1H-pyrrol-1-yl)carbamate;N-(1H-pyrrol-1-yl)(tert-butoxy)formamide;937046-95-2;EC 810-523-3;AKOS006314517;DTXSID40678242;SY020948;MFCD09863891;CS-W001687;BCP30713;JDOTVVAIWOCYFL-UHFFFAOYSA-N;tert-Butyl1H-pyrrol-1-ylcarbamate;MB07933;tert-butyl N-pyrrol-1-ylcarbamate;NS00004420;EN300-180266;DB-079666;1-(Boc-amino)pyrrole;AS-54675;SCHEMBL59469;

标识符

MDL:
MFCD09863891
InChIKey:
JDOTVVAIWOCYFL-UHFFFAOYSA-N
Inchi:
1S/C9H14N2O2/c1-9(2,3)13-8(12)10-11-6-4-5-7-11/h4-7H,1-3H3,(H,10,12)
SMILES:
O=C(NN1C=CC=C1)OC(C)(C)C

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)物化性质

实验特性

  • LogP : 2.03970
  • PSA : 43.26000
  • 折射率 : 1.505
  • 密度 : 1.06

计算特性

  • 精确分子量 : 182.10600
  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 4
  • 同位素质量 : 182.106
  • 重原子数量 : 13
  • 复杂度 : 181
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.7
  • 拓扑分子极性表面积 : 43.3A^2

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)安全信息

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)海关数据

海关编码:
2933990090
海关数据:

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)推荐厂家 更多厂家(18)

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)合成路线

合成路线:1 步
反应条件:
参考文献:
Green preparation of remdesivir intermediate 7-iodopyrrolo[2,1-F][1,2,4]triazine-4-amine
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted bicyclic heteroaryls as CRTH2 antagonists
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Method for preparing 6-bromo-3H-pyrrolo[2,1-f][1,2,4]triazin-4-one by esterification
, China, , ,
合成路线:1 步
参考文献:
Facile and Scalable Methodology for the Pyrrolo[2,1-f][1,2,4]triazine of Remdesivir
Roy, Sarabindu; Yadaw, Ajay; Roy, Subho; Sirasani, Gopal; Gangu, Aravind; et al, Organic Process Research & Development, 2022, 26(1), 82-90
合成路线:1 步
反应条件:
参考文献:
Synthesis of 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine
Zheng, Jun; Cao, Guo-rui, Huaxue Shiji, 2020, 42(5), 608-611
合成路线:1 步
反应条件:
参考文献:
Method for preparing 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine as GS-441524 intermediate for treating feline infectious peritonitis (FIP)
, China, , ,
合成路线:1 步
反应条件:
参考文献:
N-heterocycle-containing derivative and its pharmaceutical application
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of the monohydrate of rogaratinib hydrochloride and solid states thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Dibromides of BOC-protected 1-aminopyrrole and 4-amino-1,2,4-triazole: synthesis, X-ray molecular structure, and NMR behavior
Yamamoto, Takakazu; Tanaka, Gentaro; Fukumoto, Hiroki; Koizumi, Take-aki, Heterocycles, 2009, 78(1), 117-125
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of pyrrolo[2,1-f][1,2,4]triazin-4-ylamines as IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparing method and application of tricyclic compounds capable of inhibiting EGFR kinase mutant
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of multicyclic heterocycles as Janus kinase inhibitors for treating cancer or modifying an immune response
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Pyrrolopyridazines and pyrrolotriazines as janus kinase inhibitors and their preparation and use for the treatment of JAK-associated diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of piperidine derivatives as immunosuppressant for the treatment of diseases associated with pathologic JAK3 activation
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Discovery and Process Synthesis of Novel 2,7-Pyrrolo[2,1-f][1,2,4]triazines
Thieu, Tho; Sclafani, Joseph A.; Levy, Daniel V.; McLean, Andrew; Breslin, Henry J.; et al, Organic Letters, 2011, 13(16), 4204-4207
合成路线:1 步
反应条件:
参考文献:
Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor
Collin, Marie-Pierre ; Lobell, Mario; Huebsch, Walter; Brohm, Dirk; Schirok, Hartmut; et al, ChemMedChem, 2018, 13(5), 437-445
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted 4-aminopyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of CDK kinase inhibitors
, World Intellectual Property Organization, , ,

(1H-吡咯-1-基)氨基甲酸叔丁酯(937046-95-2)参考资料

Beilstein:
N178332
PubChem CID: